Radiopharm Theranostics Limited (ASX:RAD)
Australia · Delayed Price · Currency is AUD 0.0140
0.00 (0.00%)
Jul 31, 2026, 4:11 PM AEST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of 55 million as of July 31, 2026. Its market cap has increased by 5.71% in one year.
Market Cap
55.00M
Enterprise Value
18.65M
Revenue
16.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
ChartMarket Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from 101.33M to 55.00M, a decrease of -45.72%. That is a compound annual growth rate of -12.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 55.00M | -37.92% |
| Dec 31, 2025 | 88.61M | 68.31% |
| Dec 31, 2024 | 52.65M | 91.43% |
| Dec 29, 2023 | 27.50M | -20.28% |
| Dec 30, 2022 | 34.50M | -65.53% |
| Dec 31, 2021 | 100.07M | -1.25% |
| Nov 25, 2021 | 101.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prescient Therapeutics | 85.17M |
| LTR Pharma | 82.71M |
| Arovella Therapeutics | 76.15M |
| Avecho Biotechnology | 72.78M |
| Immutep | 69.26M |
| Amplia Therapeutics | 64.16M |
| Entropy Neurodynamics | 57.11M |
| Botanix Pharmaceuticals | 51.95M |